Last10K.com

Nexien Biopharma, Inc. (NXEN) SEC Filing 10-Q Quarterly report for the period ending Monday, September 30, 2019

Nexien Biopharma, Inc.

HISTORY TOOLS
CIK: 1625288 Ticker: NXEN
Document and Entity Information - shares
3 Months Ended
Sep. 30, 2019
Nov. 12, 2019
Document And Entity Information  
Entity Registrant NameNEXIEN BIOPHARMA, INC. 
Entity Central Index Key0001625288 
Document Type10-Q 
Document Period End DateSep. 30, 2019 
Amendment Flagfalse 
Current Fiscal Year End Date--06-30 
Entity Reporting Status CurrentYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Business Flagtrue 
Entity Emerging Growth Companytrue 
Entity Ex Transition Periodfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 53,984,004
Document Fiscal Period FocusQ1 
Document Fiscal Year Focus2020 

View differences made from one quarter to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..

Continue

Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Nexien Biopharma, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Exhibit 32.2: Section 1350 Certification
Ticker: NXEN
CIK: 1625288
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-19-016795
Submitted to the SEC: Tue Nov 12 2019 6:26:08 AM EST
Accepted by the SEC: Tue Nov 12 2019
Period: Monday, September 30, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nxen/0001493152-19-016795.htm